Janney Montgomery Scott LLC Has $8.94 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Janney Montgomery Scott LLC trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 97,285 shares of the medical device company’s stock after selling 2,937 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Cooper Companies were worth $8,943,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Victory Capital Management Inc. increased its holdings in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares during the last quarter. Franklin Resources Inc. grew its holdings in Cooper Companies by 194.0% during the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after purchasing an additional 32,260 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of Cooper Companies by 6.6% in the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after purchasing an additional 14,687 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares during the last quarter. Finally, Bank of Montreal Can boosted its holdings in shares of Cooper Companies by 51.4% during the 3rd quarter. Bank of Montreal Can now owns 326,520 shares of the medical device company’s stock worth $35,845,000 after buying an additional 110,878 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on COO. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company lifted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Up 1.7 %

Shares of COO opened at $99.35 on Tuesday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $95.95 and a two-hundred day moving average price of $99.50. The stock has a market cap of $19.83 billion, a price-to-earnings ratio of 50.95, a P/E/G ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the previous year, the firm earned $0.87 EPS. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis. Equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.